Citadel Investment Advisory’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.4M | Sell |
18,316
-140
| -0.8% | -$26K | 1.65% | 14 |
|
|
2025
Q1 | $3.87M | Buy |
18,456
+75
| +0.4% | +$15.7K | 1.9% | 10 |
|
|
2024
Q4 | $3.27M | Buy |
18,381
+2,137
| +13% | +$380K | 1.69% | 12 |
|
|
2024
Q3 | $3.21M | Buy |
16,244
+400
| +3% | +$79K | 1.69% | 13 |
|
|
2024
Q2 | $2.72M | Hold |
15,844
| – | – | 1.55% | 13 |
|
|
2024
Q1 | $2.89M | Sell |
15,844
-235
| -1% | -$42.8K | 1.63% | 13 |
|
|
2023
Q4 | $2.49M | Hold |
16,079
| – | – | 1.53% | 15 |
|
|
2023
Q3 | $2.4M | Hold |
16,079
| – | – | 1.57% | 14 |
|
|
2023
Q2 | $2.17M | Sell |
16,079
-325
| -2% | -$43.8K | 1.4% | 18 |
|
|
2023
Q1 | $2.61M | Sell |
16,404
-350
| -2% | -$55.8K | 1.78% | 14 |
|
|
2022
Q4 | $2.71M | Sell |
16,754
-190
| -1% | -$30.7K | 1.85% | 13 |
|
|
2022
Q3 | $2.27M | Buy |
16,944
+200
| +1% | +$26.8K | 1.73% | 15 |
|
|
2022
Q2 | $2.57M | Sell |
16,744
-600
| -3% | -$91.9K | 1.74% | 14 |
|
|
2022
Q1 | $2.81M | Sell |
17,344
-242
| -1% | -$39.2K | 1.63% | 13 |
|
|
2021
Q4 | $2.38M | Hold |
17,586
| – | – | 1.39% | 20 |
|
|
2021
Q3 | $1.9M | Hold |
17,586
| – | – | 1.18% | 21 |
|
|
2021
Q2 | $1.98M | Sell |
17,586
-300
| -2% | -$33.8K | 1.22% | 20 |
|
|
2021
Q1 | $1.94M | Buy |
17,886
+11,450
| +178% | +$1.24M | 1.27% | 20 |
|
|
2020
Q4 | $690K | Buy |
+6,436
| New | +$690K | 0.49% | 49 |
|